Overcoming insulin "resistance": Assisting patients in transitioning to insulin therapy
- Reshuffling the Medication Choices for Type 2 Diabetes. Scherger, Joseph E. // Internal Medicine Alert;12/15/2008, Vol. 30 Issue 23, p177
Leaders of the American Diabetes Association (ADA) joined with leaders of the European Association for the Study of Diabetes to reconsider the treatment strategy for patients with Type 2 diabetes. Insulin and sulfonylureas now join metformin as tier 1 medications. Tier 2 medications include the...
- Should Sulfonylureas Remain an Acceptable First-Line Add-on to Metformin Therapy in Patients With Type 2 Diabetes? Yes, They Continue to Serve Us Well! Abrahamson, Martin J. // Diabetes Care;Jan2015, Vol. 38 Issue 1, p166
The article discusses research on the continued use of sulfonylureas (SU) as first-line add-on to metformin in treating type 2 diabetes. Topics include the American Diabetes Association (ADA) and the American Association of Clinical Endocrinologists (AACE), issues on cardiac safety and...
- Should Sulfonylureas Remain an Acceptable First-Line Add-on to Metformin Therapy in Patients With Type 2 Diabetes? No, It's Time to Move On! Genuth, Saul // Diabetes Care;Jan2015, Vol. 38 Issue 1, p170
The article discusses the research supporting the discontinuations of using sulfonylureas (SU) as a first-line add on to metformin in treating type 2 diabetes. Topics include the joint recommendations of the American Diabetes Association (ADA) and the European Association for the Study of...
- American Diabetes Association Annual Meeting, 1998. Bloomgarden, Zachary T. // Diabetes Care;Mar1999, Vol. 22 Issue 3, p517
Reports on topics covered during the American Diabetes Association 1998 Annual Meeting and Scientific Sessions held in Chicago. Information on insulin resistance syndrome and type 2 diabetes; Major hormonal effector of increased glucose production during exercise; Epidemiologic factors in...
- Comparable glucose control achieved with third-line therapies. Kalvaitis, Katie // Endocrine Today;Jun2011, Vol. 9 Issue 6, p21
The article discusses research on the glycemic control of patients with type 2 diabetes who received metformin and sulfonylurea, by J. L. Gross and colleagues, published in "Annals of Internal Medicine."
- Safety and efficacy of oral medications for type 2 diabetes. Taylor, James R. // Endocrine Today;7/25/2008, Vol. 6 Issue 13, p10
The article discusses research being done on oral medications for type 2 diabetes. It references a study by S. Bolen et al, published in a 2007 issue of the "Annals of Internal Medicine." Researchers identified evidence relating to the effect of oral medications on improving intermediate...
- Four-Year Durability of Initial Combination Therapy with Sitagliptin and Metformin in Patients with Type 2 Diabetes in Clinical Practice; COSMIC Study. Ku, Eu Jeong; Jung, Kyong Yeon; Kim, Yoon Ji; Kim, Kyoung Min; Moon, Jae Hoon; Choi, Sung Hee; Cho, Young Min; Park, Kyong Soo; Jang, Hak Chul; Lim, Soo; Ahrén, Bo // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1
Objectives: We investigated the efficacy of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes for 4 years in clinical practice. Methods: Between 2009 and 2010, we reviewed 1,178 patients with type 2 diabetes (HbA1câ‰¥7.5% or 58 mmol/mol) prescribed...
- INSULIN & TYPE 2. // Woman's Day (Australian Consolidated Press);2/11/2008, Vol. 60 Issue 6, p64
The article provides an answer to a question on whether one will get type 2 diabetes if a person was diagnosed with insulin resistance.
- Serum Concentrations of Soluble Vascular Cell Adhesion Molecule-1 and E-Selectin Are Elevated in Insulin-Resistant Patients With Type 2 Diabetes. Matsumoto, Kazunari; Sera, Yasunori; Miyake, Selbei; Abe, Yasuyo; Ueki, Yukitaka // Diabetes Care;Sep2001, Vol. 24 Issue 9, p1697
Provides information on a study which investigated the direct association between insulin resistance and the elevation of soluble adhesion molecules in type 2 diabetic patients. Formula for the K index of short insulin tolerance test; Clinical characteristics of the patients studied.